Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section

The Effect of Addition of Tramadol to Levobupivacaine in Continuous Wound Infusion for Postoperative Pain Treatment in Cesarean Section

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01916915

Enrollment

Registered

2013-08-06

Start date

2013-07-31

Completion date

2016-03-31

Last updated

2016-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

Patients experience considerable amount of pain after cesarean section. The aim of this study is to investigate the effect of tramadol (an opioid pain killer) added to levobupivacaine (a local anesthetic) in continuous wound infusion (which is done by placing a catheter in the incision) after cesarean sections.

Interventions

DRUGTramadol infusion via wound catheter

DRUGLevobupivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Planned cesarean section * American Society of Anesthesiologists Class I-II

Exclusion criteria

* Patients refusing to enroll in the study * Serious coagulopathy * Serious systemic disease * Story of allergy to drugs being used in the study * Morbid obesity (Body mass index \> 30)

Design outcomes

Primary

Measure	Time frame
lowering of pain as measured by visual analogue scores	forty eight hours after the operation

Secondary

Measure	Time frame
total additional analgesic consumption	forty eight hours after the operation

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026